Yahoo
BSE - Delayed Quote INR

Anuh Pharma Limited (ANUHPHR.BO)

84.53 -2.56 (-2.94%)
At close: 3:29:31 PM GMT+5:30
View in AlphaSpace Currency in INR All numbers in thousands
Financial statements are getting an update on November 9
Preview it now to see what’s changing.
Learn more
Breakdown
TTM
3/31/2026
3/31/2025
3/31/2024
3/31/2023
Total Revenue
7,789,884
7,716,574
6,615,149
6,470,043
5,274,860
Cost of Revenue
5,953,455
5,996,608
4,993,691
4,866,611
4,014,824
Gross Profit
1,836,429
1,719,966
1,621,458
1,603,432
1,260,036
Operating Expense
1,206,211
1,150,537
1,053,056
926,766
815,551
Operating Income
630,218
569,429
568,402
676,666
444,485
Net Non Operating Interest Income Expense
-1,422
-3,500
1,940
2,163
-2,965
Pretax Income
601,964
542,214
610,053
783,098
474,704
Tax Provision
160,266
131,753
136,534
182,523
112,908
Net Income Common Stockholders
441,698
410,461
473,519
600,575
361,796
Diluted NI Available to Com Stockholders
441,698
410,461
473,519
600,575
361,796
Basic EPS
3.58
4.10
2.36
5.99
3.61
Diluted EPS
3.58
4.10
2.36
5.99
3.61
Basic Average Shares
100,224
100,224
100,224
100,224
100,224
Diluted Average Shares
100,224
100,224
100,224
100,224
100,224
Rent Expense Supplemental
--
5,796
4,818
3,973
3,780
Total Expenses
7,159,666
7,147,145
6,046,747
5,793,377
4,830,375
Net Income from Continuing & Discontinued Operation
441,698
410,461
473,519
600,575
361,796
Normalized Income
400,682.93
382,512.56
422,441.94
519,974.78
328,615.80
Interest Income
--
6,050
14,364
11,734
4,498
Interest Expense
2,645
4,723
6,193
3,536
2,184
Net Interest Income
-1,422
-3,500
1,940
2,163
-2,965
EBIT
604,609
546,937
616,246
786,634
476,888
EBITDA
717,609
660,759
703,640
872,469
573,890
Reconciled Cost of Revenue
5,953,455
5,996,608
4,993,691
4,866,611
4,014,824
Reconciled Depreciation
113,000
113,822
87,394
85,835
97,002
Net Income from Continuing Operation Net Minority Interest
441,698
410,461
473,519
600,575
361,796
Total Unusual Items Excluding Goodwill
55,897
36,920
65,804
105,096
43,535
Total Unusual Items
55,897
36,920
65,804
105,096
43,535
Normalized EBITDA
661,712
623,839
637,836
767,373
530,355
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
14,881.93
8,971.56
14,726.94
24,495.78
10,354.80
3/31/2023 - 7/8/2002

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: